WHO ICTRP trial
EFFICACY OF NEBULIZED MAGNESIUM SULPHATE AS A BRONCHODILATOR IN CLINICALLY…
CTRI/2022/03/040848 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/03/040848 |
|---|---|
| Public title | EFFICACY OF NEBULIZED MAGNESIUM SULPHATE AS A BRONCHODILATOR IN CLINICALLY DIAGNOSED CASES OF BRONCHIOLITIS (mostly due to viral infection in 2m to 2yr children characterised by fever, cough, wheezing, tachpynea, retractions and respiratory distress.) |
| Scientific title | EFFICACY OF NEBULIZED MAGNESIUM SULPHATE AS A BRONCHODILATOR IN CLINICALLY DIAGNOSED CASES OF BRONCHIOLITIS |
| Primary sponsor | AFMRC PROJECT |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: J219- Acute bronchiolitis, unspecified |
| Interventions | Intervention1: magnesium sulphate: 40mg/kg of magnesium sulfate will be given as nebulisation 3doses at 20min interval and then every 4hourly upto 24 hours. Control Intervention1: Epinephrine: 0.1ml/kg of epinephrine 1/1000 3 doses of… |
| Registration date | Jul 3, 2022 |
| Target size | 150 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: